文献速递血管炎

法国专家中心连续随访巨细胞动脉炎患者的真实世界死因分析

Real-life analysis of the causes of death in patients consecutively followed for giant cell arteritis in a French centre of expertise.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究回顾性分析2000年至2019年法国一专家中心470例连续巨细胞动脉炎(GCA)患者,其中120例死亡,获取101例医疗档案。心血管事件是主要死因(41%),其次为感染(22%)、老年状况(17%)和癌症(15%)。多变量分析显示既往冠心病、诊断时卒中、随访期间感染和诊断时发热为死亡的预测因素。

要点

  • 心血管事件占GCA患者死因的41%,为最常见死因。
  • 感染致死患者多持续使用糖皮质激素且累积剂量更高。
  • 既往冠心病、诊断时卒中、随访期感染和诊断时发热为死亡预测因素。

核心结论

  • 心血管事件是GCA患者最主要的直接死因,其次为感染、老年状况和癌症。
  • 既往冠心病、诊断时卒中、随访期间任何感染及诊断时发热与死亡风险独立相关。

研究设计与样本

  • 回顾性分析法国一专家中心2000年1月至2019年12月连续随访的470例GCA患者。
  • 120例死亡患者中获取101例医疗档案进行死因分析。

主要发现

  • 心血管事件致死41例(41%),感染22例(22%),老年状况(跌倒或衰老恶化)17例(17%),癌症15例(15%)。
  • 心血管死亡者男性更多(46% vs 27%;P=0.04),既往冠心病史更多(29% vs 8%;P=0.006)。
  • 老年状况死亡者骨质疏松更多(56% vs 17%;P=0.0009),多已停用糖皮质激素(76% vs 33%;P=0.001)。
  • 多变量分析死亡预测因素:既往冠心病(HR 2.39;95%CI 1.27,4.21;P=0.008)、诊断时卒中(HR 2.54;95%CI 1.05,5.24;P=0.04)、随访期间感染(HR 1.93;95%CI 1.24,2.98;P=0.004)、诊断时发热(HR 1.99;95%CI 1.16,3.28;P=0.01)。

临床怎么用

  • 对GCA患者应重视心血管事件风险评估与管理,尤其男性及有冠心病史者。
  • 使用糖皮质激素者需警惕感染风险,尤其累积剂量较高者。
  • 既往冠心病、诊断时卒中、随访期感染或诊断时发热者死亡风险更高,需加强监测。
  • 对已停用糖皮质激素的老年患者应关注骨质疏松及跌倒等老年综合征。

局限性

  • 回顾性单中心研究,120例死亡中仅获取101例医疗档案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe, in a real-life setting, the direct causes of death in a cohort of consecutive patients with GCA. METHODS: We retrospectively analysed the deaths that occurred in a cohort of 470 consecutive GCA patients from a centre of expertise between January 2000 and December 2019. Among the 120 patients who died, we retrieved data from the medical files of 101 patients. RESULTS: Cardiovascular events were the dominant cause of death (n = 41, 41%) followed by infections (n = 22, 22%), geriatric situations (i.e. falls or senile deterioration; n = 17, 17%) and cancers (n = 15, 15%). Patients in each of these four groups were compared with the other deceased patients pooled together. Patients who died from cardiovascular events were more frequently male (46 vs 27%; P = 0.04) with a past history of coronary artery disease (29 vs 8%; P = 0.006). Patients who died from infections mostly had ongoing glucocorticoid treatment (82 vs 53%; P = 0.02) with higher cumulative doses (13 994 vs 9150 mg; P = 0.03). Patients who died from geriatric causes more frequently had osteoporosis (56 vs 17%; P = 0.0009) and had mostly discontinued glucocorticoid treatment (76 vs 33%; P = 0.001). The predictive factors of death in multivariate analysis were a history of coronary disease [hazard ratio (HR) 2.39; 95% CI 1.27, 4.21; P = 0.008], strokes at GCA diagnosis (HR 2.54; 95% CI 1.05, 5.24; P = 0.04), any infection during follow-up (HR 1.93; 95% CI 1.24, 2.98; P = 0.004) and fever at GCA diagnosis (HR 1.99; 95% CI 1.16, 3.28; P = 0.01). CONCLUSION: Our study provides real-life insight on the cause-specific mortality in GCA patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Antonini L, Dumont A, Lavergne A, et al. Real-life analysis of the causes of death in patients consecutively followed for giant cell arteritis in a French centre of expertise. Rheumatology (Oxford). 2021. PMID: 33693495. doi:10.1093/rheumatology/keab222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。